样式: 排序: IF: - GO 导出 标记为已读
-
Genotype–phenotype correlations in children with Gitelman syndrome Clin. Exp. Nephrol. (IF 2.3) Pub Date : 2024-03-13
Abstract Background This study aimed to analyze genotype–phenotype correlations in children with Gitelman syndrome (GS). Methods This multicenter retrospective study included 50 Korean children diagnosed with SLC12A3 variants in one or both alleles and the typical laboratory findings of GS. Genetic testing was performed using the Sanger sequencing except for one patient. Results The median age at the
-
Frequency and prognosis of peritoneal dialysis-associated peritonitis in children Clin. Exp. Nephrol. (IF 2.3) Pub Date : 2024-03-12
Abstract Background Peritonitis is the leading cause of peritoneal dialysis (PD) discontinuation. However, few data concern risk factors of peritonitis development and catheter removal caused by treatment failure in pediatric patients. Methods This single-center, retrospective study analyzed data from pediatric patients who underwent chronic PD between March 2002 and June 2022. The incidence rates
-
Impact of dietary habits on renal function in Saku, a rural Japanese town: a cohort study Clin. Exp. Nephrol. (IF 2.3) Pub Date : 2024-03-12 Keika Adachi, Marie Yasuda, Makiko Ida, Takeshi Kanda, Akemi Morita, Shu Wakino, Shaw Watanabe, Hiroshi Itoh
Background High protein intake leads to a decline in renal function in the advanced stages of chronic kidney disease (CKD). An effective diet for maintaining renal function in healthy individuals or patients in the early stages of CKD has not been established. This cohort study was conducted in Saku, Nagano Prefecture, Japan, to investigate the impact of dietary habits on renal function. Methods In
-
Cellular and humoral immune responses to COVID-19 booster vaccination in Japanese dialysis patients Clin. Exp. Nephrol. (IF 2.3) Pub Date : 2024-03-08 Ayumi Yoshifuji, Masataro Toda, Emi Oyama, Tetsuo Nakayama, Setsuko Mise-Omata, Kan Kikuchi, Mamoru Yoshizawa, Naohiko Kato, Haruki Wakai, Kiyoto Koibuchi, Kohkichi Morimoto, Yoshifumi Uwamino, Ho Namkoong, Ayako Shibata, Kaoru Wakabayashi, Motoko Fujino, Motoaki Komatsu, Naoki Mochizuki, Norihiko Kondo, Akihiko Yoshimura, Naoki Hasegawa, Munekazu Ryuzaki
-
Left ventricular hypertrophy and left atrial diameter are associated with mortality risk in haemodialysis patients: a retrospective cohort study Clin. Exp. Nephrol. (IF 2.3) Pub Date : 2024-03-08 Jiuxu Bai, Wanqing Huang, Yanping Zhang, Lin Wei, Chen Zhao, Zhuo Ren, Qian Wang, Kaiming Ren, Ning Cao
-
Association between glycated albumin and sudden death in patients undergoing hemodialysis Clin. Exp. Nephrol. (IF 2.3) Pub Date : 2024-03-04 Yoshiki Kaizu, Masaharu Nagata, Shinako Kaizu, Yueling Qie, Kazo Kaizu, Shigeru Tanaka, Toshiaki Nakano, Takanari Kitazono
-
Detecting and exploring kidney-derived extracellular vesicles in plasma Clin. Exp. Nephrol. (IF 2.3) Pub Date : 2024-03-04 Shintaro Komatsu, Noritoshi Kato, Hiroki Kitai, Yoshio Funahashi, Yuhei Noda, Shoma Tsubota, Akihito Tanaka, Yuka Sato, Kayaho Maeda, Shoji Saito, Kazuhiro Furuhashi, Takuji Ishimoto, Tomoki Kosugi, Shoichi Maruyama, Kenji Kadomatsu
-
Consequences of kidney donation by age in Japanese living kidney donors: a single-center study Clin. Exp. Nephrol. (IF 2.3) Pub Date : 2024-03-04 Masatomo Ogata, Kiyomi Osako, Maho Terashita, Takamasa Miyauchi, Yuko Sakurai, Kazunobu Shinoda, Hideo Sasaki, Yugo Shibagaki, Masahiko Yazawa
-
Cell division cycle 42 attenuates high glucose-treated renal tubular epithelial cell apoptosis, fibrosis, and inflammation, but activates the PAK1/AKT pathway Clin. Exp. Nephrol. (IF 2.3) Pub Date : 2024-02-28 Shanshan Zheng, Na Zhao, Chuwen Feng, Jian Ma
-
Comparison between the 0- and 30-s balloon dilation time in percutaneous transluminal angioplasty for restenosed arteriovenous fistula among hemodialysis patients: a multicenter, prospective, randomized trial (CARP study) Clin. Exp. Nephrol. (IF 2.3) Pub Date : 2024-02-28 Tomoki Saiki, Kensuke Sasaki, Shigehiro Doi, Akira Takahashi, Yosuke Osaki, Naoki Ishiuchi, Yujiro Maeoka, Toru Kawai, Koichiro Kawaoka, Shunsuke Takahashi, Takuo Nagai, Taisuke Irifuku, Ayumu Nakashima, Takao Masaki
-
Perspectives on the optimal timing of advance care planning among Japanese patients undergoing dialysis and clinicians: a cross-sectional study Clin. Exp. Nephrol. (IF 2.3) Pub Date : 2024-02-25 Yasushi Tsujimoto, Takuya Aoki, Sayaka Shimizu, Hiroo Kawarazaki, Kaori Kohatsu, Takeshi Nakata, Ann M. O’Hare, Yugo Shibagaki, Yosuke Yamamoto, Jun Miyashita
-
Urinary podocyte markers of disease activity, therapeutic efficacy, and long-term outcomes in acute and chronic kidney diseases Clin. Exp. Nephrol. (IF 2.3) Pub Date : 2024-02-25 Akihiro Fukuda, Yuji Sato, Hirotaka Shibata, Shouichi Fujimoto, Roger C. Wiggins
-
Effect of ferric citrate hydrate on fibroblast growth factor 23 and platelets in non-dialysis-dependent chronic kidney disease and non-chronic kidney disease patients with iron deficiency anemia Clin. Exp. Nephrol. (IF 2.3) Pub Date : 2024-02-25 Kyoko Ito, Tadao Akizawa, Kojo Arita, Yuko Mitobe, Norio Komatsu
-
A survey of environmental sustainability in Japanese dialysis facilities Clin. Exp. Nephrol. (IF 2.3) Pub Date : 2024-02-25
Abstract Background Dialysis practice has a particularly high environmental impact, including responsible for carbon emissions and climate change. Insufficient research has been conducted on environmental sustainability activities in dialysis therapy in Japan. Methods We conducted an online Green Survey comprising 30 question items based on a previously conducted survey in Australia. Between August
-
A multi-center randomized controlled trial to investigate potential effects of exercise therapy on renal function stratified by renal disorders and renal pathology: beneficial or harmful effect in immunoglobulin a nephropathy Clin. Exp. Nephrol. (IF 2.3) Pub Date : 2024-02-25 Takahide Kimura, Naoki Washida, Shigeaki Ohtsuki, Kazuya Sugita, Kozi Hosoya, Kiyotaka Uchiyama
-
Preference for anti-phospholipase A2 receptor antibody assay in patients with suspected membranous nephropathy: a survey study on medical practice after publication of Japanese Guidelines for Nephrotic Syndrome 2020 Clin. Exp. Nephrol. (IF 2.3) Pub Date : 2024-02-25 Sho Sasaki, Sayaka Shimizu, Izaya Nakaya, Yoshitaka Miyaoka, Masahiro Koizumi, Hiroki Nishiwaki, Tadashi Sofue, Takuji Ishimoto, Noriaki Kurita, Takehiko Wada
Background International practice guidelines advocate for the use of anti-phospholipase A2 receptor (PLA2R) antibody testing to diagnose primary membranous nephropathy (pMN). This study aimed to clarify the current status of anti-PLA2R antibody testing in the diagnosis of pMN in Japan and to scrutinize the factors associated with the implementation of this antibody test. Methods Utilizing a web-based
-
Effects of sodium-glucose co-transporter 2 inhibitors on ultrafiltration in patients with peritoneal dialysis: a protocol for a randomized, double-blind, placebo-controlled, crossover trial (EMPOWERED) Clin. Exp. Nephrol. (IF 2.3) Pub Date : 2024-02-25 Yohei Doi, Maki Shinzawa, Tetsuya Arisato, Hideaki Oka, Ayumi Matsumoto, Harumi Kitamura, Yumi Nakazono, Yoichi Nishiya, Yoshiyasu Ueda, Taro Kamimura, Terumasa Hayashi, Fumiki Yoshihara, Yoshitaka Isaka
-
Clinical significance of amphiregulin in patients with chronic kidney disease Clin. Exp. Nephrol. (IF 2.3) Pub Date : 2024-02-25
Abstract Background Amphiregulin (AREG) is a ligand of epidermal growth factor receptor (EGFR), which plays an important role in injury-induced kidney fibrosis. However, the clinical significance of serum soluble AREG in chronic kidney disease (CKD) is unclear. In this study, we elucidated the clinical significance of serum soluble AREG in CKD by analyzing the association of serum soluble AREG levels
-
The impact of low and high dialysate calcium concentrations on cardiovascular disease and death in patients undergoing maintenance hemodialysis: a systematic review and meta-analysis Clin. Exp. Nephrol. (IF 2.3) Pub Date : 2024-02-24 Keita Kamei, Shunsuke Yamada, Koji Hashimoto, Tsuneo Konta, Takayuki Hamano, Masafumi Fukagawa
-
Urine oxygenation predicts COVID-19 risk Clin. Exp. Nephrol. (IF 2.3) Pub Date : 2024-02-24 Eisei Noiri, Daisuke Katagiri, Yusuke Asai, Takeshi Sugaya, Katsushi Tokunaga
-
Performance of ChatGPT and Bard in self-assessment questions for nephrology board renewal Clin. Exp. Nephrol. (IF 2.3) Pub Date : 2024-02-14 Ryunosuke Noda, Yuto Izaki, Fumiya Kitano, Jun Komatsu, Daisuke Ichikawa, Yugo Shibagaki
Background Large language models (LLMs) have impacted advances in artificial intelligence. While LLMs have demonstrated high performance in general medical examinations, their performance in specialized areas such as nephrology is unclear. This study aimed to evaluate ChatGPT and Bard in their potential nephrology applications. Methods Ninety-nine questions from the Self-Assessment Questions for Nephrology
-
Design and rationale for an open-label, randomized, controlled pilot trial to evaluate the changes in blood uremic toxins in patients with chronic kidney disease by dietary therapy with sake lees Clin. Exp. Nephrol. (IF 2.3) Pub Date : 2024-02-10 Toshiaki Tokumaru, Tadashi Toyama, Yusuke Nakade, Hisayuki Ogura, Megumi Oshima, Shiori Nakagawa, Motoe Furuichi, Shinji Kitajima, Norihiko Sakai, Miho Shimizu, Yasunori Iwata, Takashi Wada
-
Slope of the estimated glomerular filtration rate and its associated factors among individuals with chronic kidney disease in the general Japanese population Clin. Exp. Nephrol. (IF 2.3) Pub Date : 2024-02-10 Jun Ito, Masafumi Fukagawa
-
Upward-directed exit-site of the swan-neck catheter and “Easy-to-disinfect the backside area of exit-site” may prevent PD complications Clin. Exp. Nephrol. (IF 2.3) Pub Date : 2024-02-10 Kyohei Ogawa, Masato Ikeda, Izumi Shirai, Kentaro Ohshiro, Yukio Maruyama, Takashi Yokoo, Yudo Tanno, Hiroyuki Terawaki, Tsutomu Sakurada, Kazuhiro Yoshikawa, Hironobu Inoue, Chieko Higuchi, Tomohiro Kaneko, Fumiaki Nogaki, Atsushi Ueda, Yoshitaka Maeda
-
A mechanistic reflection on the relationship between maternal and neonatal serum creatinine values at delivery Clin. Exp. Nephrol. (IF 2.3) Pub Date : 2024-02-07 Karel Allegaert
-
Protein intake and its relationship with frailty in chronic kidney disease Clin. Exp. Nephrol. (IF 2.3) Pub Date : 2024-02-07 Nobuyuki Shirai, Suguru Yamamoto, Yutaka Osawa, Atsuhiro Tsubaki, Shinichiro Morishita, Toshiko Murayama, Ichiei Narita
-
Rationale and design of the Japanese Biomarkers in Nephrotic Syndrome (J-MARINE) study Clin. Exp. Nephrol. (IF 2.3) Pub Date : 2024-01-25 Shimon Kurasawa, Sawako Kato, Takaya Ozeki, Shin’ichi Akiyama, Takuji Ishimoto, Masashi Mizuno, Naotake Tsuboi, Noritoshi Kato, Tomoki Kosugi, Shoichi Maruyama
-
Prevalence and prognosis of severe hyperkalemia in the emergency department Clin. Exp. Nephrol. (IF 2.3) Pub Date : 2024-01-19 Teppei Koyama, Kita Youhei, Ryuichiro Makinouchi, Shinji Machida, Naohiko Imai
-
Cytosolic mtDNA–cGAS–STING axis contributes to sepsis-induced acute kidney injury via activating the NLRP3 inflammasome Clin. Exp. Nephrol. (IF 2.3) Pub Date : 2024-01-19 Xi Luo, Yang Zhao, Yunpeng Luo, Jian Lai, Jiemei Ji, Jiao Huang, Yuanyuan Chen, Ziru Liu, Jingchen Liu
-
Urine albumin-to-creatinine ratio diurnal variation rate predicts outcomes in idiopathic membranous nephropathy Clin. Exp. Nephrol. (IF 2.3) Pub Date : 2024-01-19 Xiaoqing Chen, Yong Zhang, Liqun Yan, Yangbin Xie, Shujing Li, Yongze Zhuang, Liping Wang
-
NT-pro BNP level at dialysis initiation is a useful biomarker for predicting hospitalization for ischemic heart disease Clin. Exp. Nephrol. (IF 2.3) Pub Date : 2024-01-19 Homare Shimohata, Joichi Usui, Takashi Tawara-Iida, Itaru Ebihara, Takashi Ishizu, Yoshitaka Maeda, Hiroaki Kobayashi, Daichi Numajiri, Ayaka Kaneshige, Masatoshi Sega, Marina Yamashita, Kentaro Ohgi, Hiroshi Maruyama, Mamiko Takayasu, Kouichi Hirayama, Masaki Kobayashi, Kunihiro Yamagata
-
A case series of Fabry diseases with CKD in Japan Clin. Exp. Nephrol. (IF 2.3) Pub Date : 2024-01-09 Oi Yusei, Hajime Nagasu, Naoki Nakagawa, Seigo Terawaki, Takahito Moriwaki, Seiji Itano, Seiji Kishi, Tamaki Sasaki, Naoki Kashihara, Takanobu Otomo
-
Correction to: Efficacy and safety of entecavir for hepatitis B virus-associated glomerulonephritis with renal insufficiency Clin. Exp. Nephrol. (IF 2.3) Pub Date : 2024-01-04 Yani Yu, Lingyu Xu, Ting Xu, Chengyu Yang, Quandong Bu, Wei Zhang, Long Zhao, Yan Xu, Wei Jiang
-
Angiotensin II and post-streptococcal glomerulonephritis Clin. Exp. Nephrol. (IF 2.3) Pub Date : 2024-01-03 Jesus A. Mosquera-Sulbaran, Adriana Pedreañez, Yenddy Carrero, Juan Pablo Hernandez-Fonseca
-
Survey of Japanese nephrologists' use of clinical practice guidelines for rapidly progressive glomerulonephritis Clin. Exp. Nephrol. (IF 2.3) Pub Date : 2023-12-28
Abstract Background The guidelines in Japan for the treatment of rapidly progressive glomerulonephritis (RPGN) have been revised; the latest update was released in 2020. We investigated the actual usage of the new guidelines in Japan. Methods We distributed a survey electronically to board-certified nephrologists throughout Japan from December 15, 2021 to January 31, 2022. The survey focused on anti-neutrophil
-
AHA Life’s Essential 8 and new-onset CKD: a prospective cohort study from the UK Biobank Clin. Exp. Nephrol. (IF 2.3) Pub Date : 2023-12-28 Yong-Xiang Ruan, Mao-Xiong Wu, Jing-Wei Gao, Da-Chuan Guo, Yang-Wei Cai, Ze-Gui Huang, Wan-Bing He, Yang-Xin Chen, Jing-Feng Wang, Hai-Feng Zhang
-
Association of abnormalities in electrocardiography and ultrasonic echocardiography with the occurrence of cardiovascular disease in patients with advanced chronic kidney disease Clin. Exp. Nephrol. (IF 2.3) Pub Date : 2023-12-23
Abstract Background In patients with chronic kidney disease (CKD), the incidence of cardiovascular disease (CVD) increases with disease progression. CVD screening tests in those with CKD were researched to determine whether abnormalities observed in electrocardiography (ECG) and ultrasonic echocardiography (UCG) were risk factors associated with the development of CVD. Methods This study included 604
-
Relationship between the serum creatinine concentrations of preterm neonates within 24 h of birth and their mothers before delivery Clin. Exp. Nephrol. (IF 2.3) Pub Date : 2023-12-23 Wataru Shimabukuro, Shogo Nakada, Kohei Shimada, Mayumi Tsukayama, Kazuya Hamada, Hideki Goya, Noriko Kinjo, Tomohide Yoshida, Keiko Mekaru, Koichi Nakanishi
-
Association between the serum zinc level and nutritional status represented by the geriatric nutritional Rrisk index Clin. Exp. Nephrol. (IF 2.3) Pub Date : 2023-12-23 Makoto Sagasaki, Yukio Maruyama, Akio Nakashima, Akira Fukui, Takashi Yokoo
-
Differential impact of glomerular and tubule-interstitial histological changes on kidney outcome between non-proteinuric and proteinuric diabetic nephropathy Clin. Exp. Nephrol. (IF 2.3) Pub Date : 2023-11-29 Fumihiro Fukata, Masahiro Eriguchi, Hiroyuki Tamaki, Takayuki Uemura, Hikari Tasaki, Riri Furuyama, Masatoshi Nishimoto, Takaaki Kosugi, Kaori Tanabe, Katsuhiko Morimoto, Keisuke Okamoto, Masaru Matsui, Ken-ichi Samejima, Kazuhiko Tsuruya
-
Rituximab in combination with cyclosporine and steroid pulse therapy for childhood-onset multidrug-resistant nephrotic syndrome: a multicenter single-arm clinical trial (JSKDC11 trial) Clin. Exp. Nephrol. (IF 2.3) Pub Date : 2023-11-27 Kandai Nozu, Mayumi Sako, Seiji Tanaka, Yuji Kano, Yoko Ohwada, Tamaki Morohashi, Riku Hamada, Yasufumi Ohtsuka, Masafumi Oka, Koichi Kamei, Aya Inaba, Shuichi Ito, Tomoyuki Sakai, Hiroshi Kaito, Yuko Shima, Kenji Ishikura, Hidefumi Nakamura, Koichi Nakanishi, Tomoko Horinouchi, Akihide Konishi, Takashi Omori, Kazumoto Iijima
-
Impact of nutrition and inflammation indicators on peritoneal dialysis initiation and management Clin. Exp. Nephrol. (IF 2.3) Pub Date : 2023-11-23 Shunta Hori, Mitsuru Tomizawa, Kuniaki Inoue, Tatsuo Yoneda, Akira Tachibana, Tatsuki Miyamoto, Kenta Onishi, Yosuke Morizawa, Daisuke Gotoh, Yasushi Nakai, Makito Miyake, Kazumasa Torimoto, Nobumichi Tanaka, Kiyohide Fujimoto
-
Single and combination immunotherapy with chemotherapy and the risk of AKI in patients with solid cancer Clin. Exp. Nephrol. (IF 2.3) Pub Date : 2023-11-23 Germana Alves de Brito, Antonio Paulo Nassar Junior, Milton Barros e Silva, Barbara Beltrame Bettim, Benedito Jorge Pereira
-
Questionnaire survey of the frequency of dietary intake during hemodialysis and the impact of COVID-19 in Japan Clin. Exp. Nephrol. (IF 2.3) Pub Date : 2023-11-20 Hideyuki Kabasawa, Michihiro Hosojima, Ichiei Narita
-
The association between embedded catheter implantation and hospitalization costs for peritoneal dialysis initiation: a retrospective cohort study Clin. Exp. Nephrol. (IF 2.3) Pub Date : 2023-11-14 Maki Shinzawa, Ayumi Matsumoto, Harumi Kitamura, Yusuke Sakaguchi, Atsushi Takahashi, Isao Matsui, Masayuki Mizui, Ryohei Yamamoto, Yoshitaka Isaka
-
The relation between proteinuria and the severity of COVID-19 Clin. Exp. Nephrol. (IF 2.3) Pub Date : 2023-11-14 Akira Fukui, Kohei Takeshita, Akio Nakashima, Yukio Maruyama, Nobuo Tsuboi, Tokio Hoshina, Takashi Yokoo
-
Effects of NRF2 polymorphisms on safety and efficacy of bardoxolone methyl: subanalysis of TSUBAKI study Clin. Exp. Nephrol. (IF 2.3) Pub Date : 2023-11-14 Kazuaki Ikejiri, Takafumi Suzuki, Satsuki Muto, Hirotaka Takama, Kengo Yamawaki, Tatsuya Miyazawa, Itaru Urakawa, Yuichi Aoki, Akihito Otsuki, Fumiki Katsuoka, Kengo Kinoshita, Masaomi Nangaku, Tadao Akizawa, Masayuki Yamamoto
-
Erythropoietin levels after bilateral nephrectomy for renal cell carcinoma; a case report Clin. Exp. Nephrol. (IF 2.3) Pub Date : 2023-11-04 Kie Sekiguchi, Takaya Abe, Tomohiko Matsuura, Makoto Moriwaka, Kenta Takahashi, Wataru Obara
-
Practice patterns of rituximab for primary membranous nephropathy 2021 in Japan: a web-based survey of board-certified nephrologists Clin. Exp. Nephrol. (IF 2.3) Pub Date : 2023-11-04 Yoshitaka Miyaoka, Noriaki Kurita, Tadashi Sofue, Hiroki Nishiwaki, Masahiro Koizumi, Sayaka Shimizu, Sho Sasaki, Takuji Ishimoto, Takehiko Wada
-
Tenapanor for peritoneal dialysis patients with hyperphosphatemia: a phase 3 trial Clin. Exp. Nephrol. (IF 2.3) Pub Date : 2023-11-01 Masaaki Nakayama, Shuhei Kobayashi, Miho Kusakabe, Meiko Ohara, Kaoru Nakanishi, Tadao Akizawa, Masafumi Fukagawa
-
Landscape of infiltrating immune cells and related genes in diabetic kidney disease Clin. Exp. Nephrol. (IF 2.3) Pub Date : 2023-10-26 Jiao Wang, Wen Chen, Shen Chen, Guanru Yue, Ying Hu, Jixiong Xu
-
Clinical questions and good practice statements of clinical practice guidelines for management of kidney injury during anticancer drug therapy 2022. Clin. Exp. Nephrol. (IF 2.3) Pub Date : 2023-10-25 Motoko Yanagita,Satoru Muto,Hiroyuki Nishiyama,Yuichi Ando,Sumio Hirata,Kent Doi,Yutaka Fujiwara,Norio Hanafusa,Takahiro Hatta,Junichi Hoshino,Satoko Ichioka,Takamitsu Inoue,Kenji Ishikura,Taigo Kato,Hiroshi Kitamura,Yusuke Kobayashi,Yuichi Koizumi,Chihiro Kondoh,Takeshi Matsubara,Kazuo Matsubara,Koji Matsumoto,Yusuke Okuda,Yuta Okumura,Emiko Sakaida,Yugo Shibagaki,Hideki Shimodaira,Nao Takano,Akiko
-
Efficacy of dotinurad in patients with severe renal dysfunction Clin. Exp. Nephrol. (IF 2.3) Pub Date : 2023-10-21 Osamu Kurihara, Takehisa Yamada, Katsuhito Kato, Yasushi Miyauchi
-
Survival benefit of living donor kidney transplantation in patients on hemodialysis Clin. Exp. Nephrol. (IF 2.3) Pub Date : 2023-10-21 Shunsuke Goto, Hideki Fujii, Makiko Mieno, Takashi Yagisawa, Masanori Abe, Kosaku Nitta, Shinichi Nishi
-
Changes in adverse events after multiple rituximab courses in patients with complicated steroid-dependent nephrotic syndrome. Clin. Exp. Nephrol. (IF 2.3) Pub Date : 2023-10-21 Toshimasa Morishita,Shuichiro Fujinaga
-
The role of a novel mineralocorticoid receptor antagonist, finerenone, in chronic kidney disease: mechanisms and clinical advances Clin. Exp. Nephrol. (IF 2.3) Pub Date : 2023-10-17 Xinping Chen, Xuan Li, Kexin Zhang, Kexin Lian, Wenqiang Zhang, Yixin Song, Chengxia Kan, Jingwen Zhang, Fang Han, Xiaodong Sun, Zhentao Guo
-
Alleviation effects of epigallocatechin-3-gallate against acute kidney injury following severe burns Clin. Exp. Nephrol. (IF 2.3) Pub Date : 2023-10-17 Hongyan Xu, Yichao Pang, Wei Sun, Yi Luo
-
Development of pauci-immune necrotizing glomerulonephritis during pembrolizumab treatment Clin. Exp. Nephrol. (IF 2.3) Pub Date : 2023-10-17 Jun Matsumoto, Yosuke Saka, Tomohiko Naruse
-
Potential influence of dietary guidance for advanced chronic kidney disease: comment on "Prevalence of hyponatremia and associated factors in patients with chronic kidney disease: the Fukuoka Kidney Disease Registry (FKR) study". Clin. Exp. Nephrol. (IF 2.3) Pub Date : 2023-10-17 Hirofumi Sumi,Naoto Tominaga
-
Do pseudoxanthoma elasticum patients have higher prevalence of kidney stones on computed tomography compared to hospital controls? Clin. Exp. Nephrol. (IF 2.3) Pub Date : 2023-10-14 Iris M. Harmsen, Madeleine Kok, Jonas W. Bartstra, Pim A. de Jong, Wilko Spiering, Wouter Foppen
Background Pseudoxanthoma elasticum (PXE) is an autosomal recessive disease characterized by diminished inorganic plasma pyrophosphate (PPi), a strong calcification inhibitor. In addition to more typical calcification of skin, retina and arterial wall a diminished plasma PPi could lead to other ectopic calcification, such as formation of kidney stones. Objective To compare the prevalence of kidney